What's new

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 16, Status: Authorised

Apr 3, 2025 - 16:13
 0
Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 16, Status: Authorised
Read More

Tags:

Previous Article

Siemens AG to acquire lab R&D platform Dotmatics for $5.1B

Next Article

Trump unveils sweeping tariffs, sparking further turmoil in food

Related Posts

Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 14, 2025  0